Enteric fever, encompassing both typhoid and paratyphoid fever, continues to be a significant global health concern. The management of this disease is complex due to evolving antimicrobial resistance patterns. This article aims to provide a comprehensive review of effective strategies for managing enteric fever in clinical practice.
Understanding the epidemiology of enteric fever is crucial for effective management. It predominantly affects regions with poor sanitation and limited access to clean water. Diagnosis is often challenging due to non-specific symptoms. Therefore, a high index of suspicion is needed in endemic areas or in patients with relevant travel history. Blood culture remains the gold standard for diagnosis, but newer molecular techniques are emerging as valuable diagnostic tools.
The cornerstone of enteric fever management is antimicrobial therapy. However, increasing resistance to traditional first-line drugs like chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole necessitates the use of fluoroquinolones, azithromycin, or third-generation cephalosporins. It's crucial to monitor local resistance patterns and adjust treatment accordingly.
Vaccination is an important preventive measure, especially in endemic areas and for travelers. Two vaccines are currently available: the Vi polysaccharide vaccine and the live attenuated Ty21a vaccine. Hand hygiene, safe food and water practices, and improved sanitation are also crucial in preventing enteric fever.
Managing enteric fever effectively requires a multifaceted approach that includes accurate diagnosis, appropriate antimicrobial therapy, vaccination, and preventive measures. As antimicrobial resistance continues to evolve, ongoing research and surveillance are critical to adapt treatment protocols and develop new therapeutic strategies. By integrating these strategies, healthcare professionals can significantly improve patient outcomes and reduce the global burden of enteric fever.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation